A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis

Description

This study aims to determine if the CloudCath device can detect infections related to peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by patients and doctors to detect such infections.

Conditions

End Stage Renal Disease, Peritoneal Dialysis-associated Peritonitis, Peritonitis

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to determine if the CloudCath device can detect infections related to peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by patients and doctors to detect such infections.

A Prospective Clinical Study to Assess the Clinical Utility of Turbidity With the CloudCath System in Patients Using In-Home Peritoneal Dialysis

A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis

Condition
End Stage Renal Disease
Intervention / Treatment

-

Contacts and Locations

Chicopee

Dialysis Center of Western Massachusetts Llc, Chicopee, Massachusetts, United States, 01020

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * currently using peritoneal dialysis
  • * provides informed consent
  • * willing to comply with the requirements of the study
  • * has cellular data coverage at home
  • * active or history of cancer requiring chemotherapy within prior 6 months
  • * signs or symptoms of an active infection within 14 days prior to enrollment
  • * peritonitis diagnosis within 30 days prior to enrollment
  • * participating in another investigational device or drug study that may potentially affect study results
  • * other medical, social or psychological problems that, in the opinion of the investigator, exclude the study participant from the study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

CloudCath,

Glenn Chertow, MD, STUDY_DIRECTOR, Stanford University

Study Record Dates

2024-12